This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Ampio Pharmaceuticals, Inc., Dmi Acquisition Corp., Dmi Biosciences, Inc.. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Highlands Ranch, CO (US) (2012 - 2017)
- Larkspur, CO (US) (2013 - 2022)
Company Filing History:
6 out of 37 
2 out of 8 
2 out of 10 Years Active: 2012-2022
Certainly! Here is an article about inventor Richard Shimonkevitz:
Title: Innovator Spotlight: Richard Shimonkevitz
Introduction: Richard Shimonkevitz is a prolific inventor based in Larkspur, Colorado, with an impressive portfolio of 10 patents to his name. His groundbreaking work has focused on advancing treatments for T-cell mediated diseases using innovative approaches.
Latest Patents:
1. **Treatment of T-cell mediated diseases:** One of Richard Shimonkevitz's latest patents revolves around a novel method for treating T-cell mediated diseases. This invention involves the use of specific diketopiperazines to inhibit T-cell activation. Additionally, the patent covers methods for synthesizing these compounds, developing pharmaceutical compositions, and enhancing the effectiveness of protein and peptide-based medications by altering diketopiperazine content.
Career Highlights: Throughout his career, Richard Shimonkevitz has made significant contributions to the field of biopharmaceuticals. He has worked with renowned companies such as Ampio Pharmaceuticals, Inc. and DMI Biosciences, Inc., where his expertise in drug development and research has been instrumental in bringing innovative therapies to the market.
Collaborations: Richard Shimonkevitz has collaborated closely with esteemed professionals in the industry, including accomplished individuals like David Bar-Or and Raphael Bar-Or. These collaborations have enriched his research endeavors and paved the way for impactful advancements in the realm of T-cell therapies.
Conclusion: In conclusion, Richard Shimonkevitz stands out as a pioneering inventor whose dedication to addressing T-cell mediated diseases has led to groundbreaking solutions in the field of biopharmaceuticals. His inventive spirit and collaborative efforts continue to drive innovation and shape the future of healthcare.
Is there anything else you would like to know about Richard Shimonkevitz or any other inventor?
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile